Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 2670-2676, May 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thompson, E. W.
Right arrow Articles by Albini, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thompson, E. W.
Right arrow Articles by Albini, A.

Supernatants of Acquired Immunodeficiency Syndrome-related Kaposi's Sarcoma Cells Induce Endothelial Cell Chemotaxis and Invasiveness1

Erik W. Thompson, Shuji Nakamura, Thomas B. Shima, Antonella Melchiori, George R. Martin, S. Zaki Salahuddin2, Robert C. Gallo and Adriana Albini3

Laboratory of Developmental Biology and Anomalies, National Institute of Dental Research [E. W. T., T. B. S., G. R. M.], and Laboratory of Tumor Cell Biology, National Cancer Institute [S. N., S. Z. S., R. C. G.], NIH, Bethesda, Maryland 20892, and Istituto Nazionale per la Ricerca sul Cancro, Viale Benedetto XV, 10, 16132 Genoa, Italy [A. A., A. M.]

Kaposi's sarcoma (KS) in general, and acquired immunodeficiency syndrome-related KS (AIDS-KS) in particular, is a highly invasive and intensely angiogenic neoplasm of unknown cellular origin. We have recently established AIDS-KS cells in long term culture and reported the development of KS-like lesions in nude mice inoculated with these cells. Here, we have examined the in vitro invasiveness of basement membrane by AIDS-KS cells, as well as the effect(s) of their supernatants on the migration and invasiveness of human vascular endothelial cells. AIDS-KS cells were highly invasive in the Boyden chamber invasion assay and formed invasive, branching colonies in a 3-dimensional gel (Matrigel). Normal endothelial cells form tube-like structures on Matrigel. AIDS-KS cell-conditioned media induced endothelial cells to form invasive clusters in addition to tubes. KS-cell-conditioned media, when placed in the lower compartment of the Boyden chamber, stimulated the migration of human and bovine vascular endothelial cells across filters coated with either small amounts of collagen IV (chemotaxis) or a Matrigel barrier (invasion). Basic fibroblast growth factor could also induce endothelial cell chemotaxis and invasion in these assays. However, when antibodies to basic fibroblast growth factor were used the invasive activity induced by the AIDS-KS-cell-conditioned media was only marginally inhibited, suggesting that the large quantities of basic fibroblast growth factor-like material released by the AIDS-KS cells are not the main mediators of this effect. Specific inhibitors of laminin and collagenase IV action, which represent critical determinants of basement membrane invasion, blocked the invasiveness of the AIDS-KS cell-activated endothelial cells in these assays. These data indicate that KS cells appear to be of smooth muscle origin but secrete a potent inducer of endothelial cell chemotaxis and invasiveness which could be responsible for angiogenesis and the resulting highly vascularized lesions. These assays appear to be a model to study the invasive spread and angiogenic capacity of human AIDS-related KS and should prove useful in the identification of molecular mediators and potential inhibitors of neoplastic neovascularization.

1 This investigation was partially supported by a grant from the Ministero della Sanità, Progetto AIDS N. 5206 002.

2 Present address: Department of Internal Medicine, University of California, Los Angeles, CA 90033.

3 To whom requests for reprints should be addressed.

Received 10/29/90. Accepted 3/ 8/91.




This article has been cited by other articles:


Home page
J. Virol.Home page
L.-W. Qian, J. Xie, F. Ye, and S.-J. Gao
Kaposi's Sarcoma-Associated Herpesvirus Infection Promotes Invasion of Primary Human Umbilical Vein Endothelial Cells by Inducing Matrix Metalloproteinases
J. Virol., July 1, 2007; 81(13): 7001 - 7010.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. Sakimoto, K. Ohta, T. Yamazaki, S. Ohtani, H. Sahara, F. Sugawara, K. Sakaguchi, and M. Miura
{alpha}-Sulfoquinovosylmonoacylglycerol Is a Novel Potent Radiosensitizer Targeting Tumor Angiogenesis
Cancer Res., February 15, 2006; 66(4): 2287 - 2295.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. Huber, D. Vlasny, S. Jeckel, F. Stubenrauch, and T. Iftner
Gene Profiling of Cottontail Rabbit Papillomavirus-Induced Carcinomas Identifies Upregulated Genes Directly Involved in Stroma Invasion as Shown by Small Interfering RNA-Mediated Gene Silencing
J. Virol., July 15, 2004; 78(14): 7478 - 7489.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. Ferrari, M. Morini, U. Pfeffer, S. Minghelli, D. M. Noonan, and A. Albini
Inhibition of Kaposi's Sarcoma in Vivo by Fenretinide
Clin. Cancer Res., December 1, 2003; 9(16): 6020 - 6029.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Florio, M. Morini, V. Villa, S. Arena, A. Corsaro, S. Thellung, M. D. Culler, U. Pfeffer, D. M. Noonan, G. Schettini, et al.
Somatostatin Inhibits Tumor Angiogenesis and Growth via Somatostatin Receptor-3-Mediated Regulation of Endothelial Nitric Oxide Synthase and Mitogen-Activated Protein Kinase Activities
Endocrinology, April 1, 2003; 144(4): 1574 - 1584.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Albini, M. Morini, F. D'Agostini, N. Ferrari, F. Campelli, G. Arena, D. M. Noonan, C. Pesce, and S. De Flora
Inhibition of Angiogenesis-driven Kaposi's Sarcoma Tumor Growth in Nude Mice by Oral N-Acetylcysteine
Cancer Res., November 1, 2001; 61(22): 8171 - 8178.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. ALBINI, T. FLORIO, D. GIUNCIUGLIO, L. MASIELLO, S. CARLONE, A. CORSARO, S. THELLUNG, T. CAI, D. M. NOONAN, and G. SCHETTINI
Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis
FASEB J, April 1, 1999; 13(6): 647 - 655.
[Abstract] [Full Text]


Home page
J. Cell Biol.Home page
M. F. Carlevaro, A. Albini, D. Ribatti, C. Gentili, R. Benelli, S. Cermelli, R. Cancedda, and F. D. Cancedda
Transferrin Promotes Endothelial Cell Migration and Invasion: Implication in Cartilage Neovascularization
J. Cell Biol., March 24, 1997; 136(6): 1375 - 1384.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.